ArthroCare Tonsillectomy Potential, Opus Buy Boost Stock 22% In September
This article was originally published in The Gray Sheet
Executive Summary
ArthroCare Coblation technology uptake for tonsillectomy procedures and accelerated sports medicine growth aided a 22% increase in the firm's stock price in September - up $5.29 to $29.29